NASDAQ: PROF
Profound Medical Corp Stock Ownership - Who owns Profound Medical?

Insider buying vs selling

Have Profound Medical Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Arun Swarup MenawatCEO2025-05-1612,027$4.73
$56.89kBuy
Arun Swarup MenawatCEO2025-05-1510,003$4.33
$43.26kBuy

1 of 1

PROF insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PROF insiders and whales buy or sell their stock.

PROF Shareholders

What type of owners hold Profound Medical Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fil Ltd6.04%1,815,000$9.31MInstitution
Gagnon Securities LLC5.65%1,697,680$8.71MInstitution
Letko Brosseau Associates Inc4.02%1,207,850$6.20MInstitution
Timelo Investment Management Inc3.30%990,995$5.08MInstitution
Gagnon Advisors LLC2.98%896,671$4.60MInstitution
Raymond James Financial Inc2.97%892,879$4.58MInstitution
Royce Associates LP2.53%761,799$3.91MInstitution
Rosalind Advisors Inc2.30%692,185$3.55MInstitution
Arun Swarup Menawat1.95%587,089$3.01MInsider
Mmcap International Inc Spc1.60%480,859$2.47MInstitution

1 of 3

PROF vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PROF42.71%1.95%Net BuyingNet Buying
LNSR33.90%50.70%Net Buying
ANIK83.30%16.70%Net SellingNet Selling
ARAY55.57%39.48%Net Selling
LUCD10.35%41.00%Net BuyingNet Buying

Profound Medical Stock Ownership FAQ

Who owns Profound Medical?

Profound Medical (NASDAQ: PROF) is owned by 42.71% institutional shareholders, 1.95% Profound Medical insiders, and 55.34% retail investors. Arun Swarup Menawat is the largest individual Profound Medical shareholder, owning 587,089.00 shares representing 1.95% of the company. Arun Swarup Menawat's Profound Medical shares are currently valued at $3.01M.

If you're new to stock investing, here's how to buy Profound Medical stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.